FluoroPharma Medical, Inc. (FPMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Apr 29, 2025
FluoroPharma Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2007 - 2011 |
|---|---|---|---|---|---|---|
Period Ending | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2007 - 2011 |
| Net Income | -2.05 | -3.16 | -4.13 | -5.61 | -4.02 | Upgrade
|
| Depreciation & Amortization | 0.04 | 0.05 | 0.04 | 0.02 | 0.02 | Upgrade
|
| Other Amortization | 0.75 | 0.51 | 0.04 | 0.03 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.03 | - | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.13 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0 | 0.07 | 1.05 | - | Upgrade
|
| Stock-Based Compensation | 0.03 | 0.17 | 0.6 | 0.68 | 0.87 | Upgrade
|
| Other Operating Activities | -1.19 | -0.82 | -1.24 | 0.21 | -0.13 | Upgrade
|
| Change in Accounts Payable | 0.32 | 0.62 | 0.91 | 0.05 | -0.06 | Upgrade
|
| Change in Unearned Revenue | 0.41 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 0.8 | -0.04 | 0.35 | 0.1 | 0.03 | Upgrade
|
| Operating Cash Flow | -0.88 | -2.68 | -3.32 | -3.33 | -3.28 | Upgrade
|
| Capital Expenditures | -0 | -0.01 | -0.01 | -0.01 | -0.04 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.35 | - | - | Upgrade
|
| Investment in Securities | - | 0.04 | 0.57 | 1.81 | - | Upgrade
|
| Investing Cash Flow | -0 | 0.03 | 0.21 | 1.8 | -0.04 | Upgrade
|
| Short-Term Debt Issued | 0.73 | 3.35 | 2.08 | 0.33 | - | Upgrade
|
| Total Debt Issued | 0.73 | 3.35 | 2.08 | 0.33 | - | Upgrade
|
| Short-Term Debt Repaid | -0.1 | -0.49 | -0.03 | -0.06 | - | Upgrade
|
| Total Debt Repaid | -0.1 | -0.49 | -0.03 | -0.06 | - | Upgrade
|
| Net Debt Issued (Repaid) | 0.63 | 2.86 | 2.05 | 0.28 | - | Upgrade
|
| Issuance of Common Stock | - | - | 0.29 | 0.64 | 1.55 | Upgrade
|
| Other Financing Activities | -0.01 | -0.17 | -0.13 | -0.15 | -0.19 | Upgrade
|
| Financing Cash Flow | 0.62 | 2.69 | 2.22 | 1.37 | 1.36 | Upgrade
|
| Net Cash Flow | -0.27 | 0.04 | -0.89 | -0.16 | -1.96 | Upgrade
|
| Free Cash Flow | -0.88 | -2.68 | -3.33 | -3.34 | -3.32 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.09 | -0.12 | -0.14 | -0.15 | Upgrade
|
| Cash Interest Paid | 0 | 0 | - | 0.01 | - | Upgrade
|
| Cash Income Tax Paid | 0 | 0 | 0 | 0 | - | Upgrade
|
| Levered Free Cash Flow | -0.78 | -0.97 | -2.55 | 0.81 | -1.91 | Upgrade
|
| Unlevered Free Cash Flow | -0.74 | -0.99 | -2.53 | 0.81 | -1.91 | Upgrade
|
| Change in Net Working Capital | -0.54 | -0.8 | -0.42 | -2.76 | 0.17 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.